Amino Bisphosphonates Are Associated with Decreased Mortality Compared to Non-Amino Bisphosphonates in the Treatment of Multiple Myeloma
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-116976
Abstract: Introduction Osteolytic bone lesion is a hallmark of multiple myeloma (MM). Bisphosphonates have been shown to be effective inhibitors of osteoclastic activity, leading to improvement of skeletal related morbidity in MM. Based on their chemical… read more here.
Keywords: amino; amino bisphosphonates; myeloma; treatment ... See more keywords